Working…
Help guide our efforts to modernize ClinicalTrials.gov.
Send us your comments by March 14, 2020.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Right For Me: Birth Control Decisions Made Easier

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02759939
Recruitment Status : Completed
First Posted : May 3, 2016
Results First Posted : November 19, 2019
Last Update Posted : November 19, 2019
Sponsor:
Information provided by (Responsible Party):
Rachel L. Thompson, Dartmouth-Hitchcock Medical Center

Tracking Information
First Submitted Date  ICMJE February 3, 2016
First Posted Date  ICMJE May 3, 2016
Results First Submitted Date  ICMJE July 24, 2018
Results First Posted Date  ICMJE November 19, 2019
Last Update Posted Date November 19, 2019
Actual Study Start Date  ICMJE July 1, 2016
Actual Primary Completion Date December 30, 2016   (Final data collection date for primary outcome measure)
Current Primary Outcome Measures  ICMJE
 (submitted: November 17, 2019)
Shared Decision-making About Contraceptive Methods [ Time Frame: Immediately after the index health care visit (Time 1 (T1)) [for both pre-implementation and post-implementation participants] ]
Shared decision-making about contraceptive methods in the health care visit, measured using the three-item CollaboRATE measure (Barr et al., 2014; Elwyn et al., 2013). We used the version of CollaboRATE with a five-point response scale and adopted the binary scoring approach, which yields a score of 0 (no shared decision-making) and 1 (shared decision-making) for each participant. Note: 'pre-implementation participants' comprise those enrolled in the trial before clinics began implementing interventions and 'post-implementation participants' comprise those enrolled in the trial after clinics began implementing interventions (if relevant).
Original Primary Outcome Measures  ICMJE
 (submitted: April 29, 2016)
Shared Decision-making About Contraceptive Methods [ Time Frame: Immediately after the index health care visit ]
Shared decision-making about contraceptive methods in the health care visit, measured using the three-item CollaboRATE measure (Barr et al., 2014; Elwyn et al., 2013)
Change History
Current Secondary Outcome Measures  ICMJE
 (submitted: November 17, 2019)
  • Conversation About Contraception [ Time Frame: Immediately after the index health care visit (T1) [for both pre-implementation and post-implementation participants] ]
    Whether participants experienced a conversation about contraception in the health care visit, measured using a self-developed item. Note: 'pre-implementation participants' comprise those enrolled in the trial before clinics began implementing interventions and 'post-implementation participants' comprise those enrolled in the trial after clinics began implementing interventions (if relevant).
  • Satisfaction With Conversation About Contraception [ Time Frame: Immediately after the index health care visit (T1) [for both pre-implementation and post-implementation participants] ]
    Participants' satisfaction with the conversation about contraception in the health care visit, measured using an adapted item (Weisman et al., 2002). Note: 'pre-implementation participants' comprise those enrolled in the trial before clinics began implementing interventions and 'post-implementation participants' comprise those enrolled in the trial after clinics began implementing interventions (if relevant).
  • Intended Contraceptive Method(s) [ Time Frame: Immediately after the index health care visit (T1) [for both pre-implementation and post-implementation participants] ]
    What, if any, contraceptive method(s) participants intend to use in the next four weeks, measured using a self-developed checklist. Note: 'pre-implementation participants' comprise those enrolled in the trial before clinics began implementing interventions and 'post-implementation participants' comprise those enrolled in the trial after clinics began implementing interventions (if relevant).
  • Intention to Use a Highly Effective Contraceptive Method [ Time Frame: Immediately after the index health care visit (T1) [for both pre-implementation and post-implementation participants] ]
    Whether participants intend to use at least one highly effective contraceptive method in the next four weeks, derived from data on intended contraceptive method(s). Note: 'pre-implementation participants' comprise those enrolled in the trial before clinics began implementing interventions and 'post-implementation participants' comprise those enrolled in the trial after clinics began implementing interventions (if relevant).
  • Values Concordance of Intended Contraceptive Method(s) [ Time Frame: Immediately after the index health care visit (T1); 4 weeks after the index health care visit (Time 2 (T2)); 6 months after the index health care visit (Time 3 (T3)) [for both pre-implementation and post-implementation participants] ]
    Participants' perceptions of the degree of concordance between the contraceptive method(s) they intend(ed) to use and their individual values, needs, and preferences, measured using a self-developed item. Note: 'pre-implementation participants' comprise those enrolled in the trial before clinics began implementing interventions and 'post-implementation participants' comprise those enrolled in the trial after clinics began implementing interventions (if relevant).
  • Decision Regret About Intended Contraceptive Method(s) [ Time Frame: 4 weeks after the index health care visit (T2); 6 months after the index health care visit (T3) [for both pre-implementation and post-implementation participants] ]
    Participants' feelings of decision regret about the contraceptive method(s) they intended to use, measured using an adaptation of the five-item Decision Regret Scale (Brehaut et al., 2003; O'Connor, 1996). Note: 'pre-implementation participants' comprise those enrolled in the trial before clinics began implementing interventions and 'post-implementation participants' comprise those enrolled in the trial after clinics began implementing interventions (if relevant).
  • Contraceptive Method(s) Used [ Time Frame: 4 weeks after the index health care visit (T2); 6 months after the index health care visit (T3) [for both pre-implementation and post-implementation participants] ]
    What, if any, contraceptive method(s) participants used in the last four weeks, measured using a self-developed checklist. Note: 'pre-implementation participants' comprise those enrolled in the trial before clinics began implementing interventions and 'post-implementation participants' comprise those enrolled in the trial after clinics began implementing interventions (if relevant).
  • Use of a Highly Effective Contraceptive Method [ Time Frame: 4 weeks after the index health care visit (T2); 6 months after the index health care visit (T3) [for both pre-implementation and post-implementation participants] ]
    Whether participants used at least one highly effective contraceptive method in the last four weeks, derived from data on contraceptive method(s) used. Note: 'pre-implementation participants' comprise those enrolled in the trial before clinics began implementing interventions and 'post-implementation participants' comprise those enrolled in the trial after clinics began implementing interventions (if relevant).
  • Use of Intended Contraceptive Method(s) [ Time Frame: 4 weeks after the index health care visit (T2); 6 months after the index health care visit (T3) [for both pre-implementation and post-implementation participants] ]
    Whether participants used their intended contraceptive method(s) in the last four weeks, derived from data on intended contraceptive method(s) and contraceptive method(s) used. Note: 'pre-implementation participants' comprise those enrolled in the trial before clinics began implementing interventions and 'post-implementation participants' comprise those enrolled in the trial after clinics began implementing interventions (if relevant).
  • Adherence to Contraceptive Method(s) Used [ Time Frame: 4 weeks after the index health care visit (T2); 6 months after the index health care visit (T3) [for both pre-implementation and post-implementation participants] ]
    Participants' adherence to the contraceptive method(s) they used in the last four weeks, measured using a self-developed, 21-item measure. Note: 'pre-implementation participants' comprise those enrolled in the trial before clinics began implementing interventions and 'post-implementation participants' comprise those enrolled in the trial after clinics began implementing interventions (if relevant).
  • Satisfaction With Contraceptive Method(s) Used [ Time Frame: 4 weeks after the index health care visit (T2); 6 months after the index health care visit (T3) [for both pre-implementation and post-implementation participants] ]
    Participants' satisfaction with the contraceptive method(s) they used in the last four weeks, measured using a self-developed item. Note: 'pre-implementation participants' comprise those enrolled in the trial before clinics began implementing interventions and 'post-implementation participants' comprise those enrolled in the trial after clinics began implementing interventions (if relevant).
  • Unintended Pregnancy (Pregnancy Timing Preferences) [ Time Frame: 6 months after the index health care visit (T3) [for both pre-implementation and post-implementation participants] ]
    Participants' experience of one or more unintended pregnancies since the health care visit (as defined by their pregnancy timing preferences), measured using an adapted item (Centers for Disease Control and Prevention, 2012). Note: 'pre-implementation participants' comprise those enrolled in the trial before clinics began implementing interventions and 'post-implementation participants' comprise those enrolled in the trial after clinics began implementing interventions (if relevant).
  • Unintended Pregnancy (Pregnancy Seeking) [ Time Frame: 6 months after the index health care visit (T3) [for both pre-implementation and post-implementation participants] ]
    Participants' experience of one or more unintended pregnancies since the health care visit (as defined by their pregnancy seeking), measured using an adapted item (Kavanaugh & Schwarz, 2009). Note: 'pre-implementation participants' comprise those enrolled in the trial before clinics began implementing interventions and 'post-implementation participants' comprise those enrolled in the trial after clinics began implementing interventions (if relevant).
  • Unwelcome Pregnancy [ Time Frame: 6 months after the index health care visit (T3) [for both pre-implementation and post-implementation participants] ]
    Participants' experience of one or more unwelcome pregnancies since the health care visit, measured using an adapted item (Centers for Disease Control and Prevention, 2012). Note: 'pre-implementation participants' comprise those enrolled in the trial before clinics began implementing interventions and 'post-implementation participants' comprise those enrolled in the trial after clinics began implementing interventions (if relevant).
Original Secondary Outcome Measures  ICMJE
 (submitted: April 29, 2016)
  • Conversation About Contraception [ Time Frame: Immediately after the index health care visit ]
    Whether participants experienced a conversation about contraception in the health care visit, measured using a self-developed item
  • Satisfaction With Conversation About Contraception [ Time Frame: Immediately after the index health care visit ]
    Participants' satisfaction with the conversation about contraception in the health care visit, measured using an adapted item (Weisman et al., 2002)
  • Intended Contraceptive Method(s) [ Time Frame: Immediately after the index health care visit ]
    What, if any, contraceptive method(s) participants intend to use in the next four weeks, measured using a self-developed checklist
  • Intention to Use a Highly Effective Contraceptive Method [ Time Frame: Immediately after the index health care visit ]
    Whether participants intend to use at least one highly effective contraceptive method in the next four weeks, derived from data on intended contraceptive method(s)
  • Values Concordance of Intended Contraceptive Method(s) [ Time Frame: Immediately after the index health care visit; 4 weeks after the index health care visit; 6 months after the index health care visit ]
    Participants' perceptions of the degree of concordance between the contraceptive method(s) they intend(ed) to use and their individual values, needs, and preferences, measured using a self-developed item
  • Decision Regret About Intended Contraceptive Method(s) [ Time Frame: 4 weeks after the index health care visit; 6 months after the index health care visit ]
    Participants' feelings of decision regret about the contraceptive method(s) they intended to use, measured using an adaptation of the five-item Decision Regret Scale (Brehaut et al., 2003; O'Connor, 1996)
  • Contraceptive Method(s) Used [ Time Frame: 4 weeks after the index health care visit; 6 months after the index health care visit ]
    What, if any, contraceptive method(s) participants used in the last four weeks, measured using a self-developed checklist
  • Use of a Highly Effective Contraceptive Method [ Time Frame: 4 weeks after the index health care visit; 6 months after the index health care visit ]
    Whether participants used at least one highly effective contraceptive method in the last four weeks, derived from data on contraceptive method(s) used
  • Use of Intended Contraceptive Method(s) [ Time Frame: 4 weeks after the index health care visit; 6 months after the index health care visit ]
    Whether participants used their intended contraceptive method(s) in the last four weeks, derived from data on intended contraceptive method(s) and contraceptive method(s) used
  • Adherence to Contraceptive Method(s) Used [ Time Frame: 4 weeks after the index health care visit; 6 months after the index health care visit ]
    Participants' adherence to the contraceptive method(s) they used in the last four weeks, measured using a self-developed, 21-item measure
  • Satisfaction With Contraceptive Method(s) Used [ Time Frame: 4 weeks after the index health care visit; 6 months after the index health care visit ]
    Participants' satisfaction with the contraceptive method(s) they used in the last four weeks, measured using a self-developed item
  • Unintended Pregnancy (Pregnancy Timing Preferences) [ Time Frame: 6 months after the index health care visit ]
    Participants' experience of one or more unintended pregnancies since the health care visit (as defined by their pregnancy timing preferences), measured using an adapted item (Centers for Disease Control and Prevention, 2012)
  • Unintended Pregnancy (Pregnancy Seeking) [ Time Frame: 6 months after the index health care visit ]
    Participants' experience of one or more unintended pregnancies since the health care visit (as defined by their pregnancy seeking), measured using an adapted item (Kavanaugh & Schwarz, 2009)
  • Unwelcome Pregnancy [ Time Frame: 6 months after the index health care visit ]
    Participants' experience of one or more unwelcome pregnancies since the health care visit, measured using an adapted item (Centers for Disease Control and Prevention, 2012)
Current Other Pre-specified Outcome Measures
 (submitted: November 17, 2019)
  • Exposure to Video [ Time Frame: Immediately after the index health care visit (T1) [for both pre-implementation and post-implementation participants] ]
    Participants' exposure to the video and timing of exposure, measured using an adapted item (Shepherd et al., 2015). Note: 'pre-implementation participants' comprise those enrolled in the trial before clinics began implementing interventions and 'post-implementation participants' comprise those enrolled in the trial after clinics began implementing interventions (if relevant).
  • Exposure to Prompt Card [ Time Frame: Immediately after the index health care visit (T1) [for both pre-implementation and post-implementation participants] ]
    Participants' exposure to the prompt card and timing of exposure, measured using a self-developed item. Note: 'pre-implementation participants' comprise those enrolled in the trial before clinics began implementing interventions and 'post-implementation participants' comprise those enrolled in the trial after clinics began implementing interventions (if relevant).
  • Use of Three Questions [ Time Frame: Immediately after the index health care visit (T1) [for both pre-implementation and post-implementation participants] ]
    Participants' use of each of the three patient questions in the health care visit, measured using three adapted items (Shepherd et al., 2015). Note: 'pre-implementation participants' comprise those enrolled in the trial before clinics began implementing interventions and 'post-implementation participants' comprise those enrolled in the trial after clinics began implementing interventions (if relevant).
  • Exposure to Decision Aid(s) [ Time Frame: Immediately after the index health care visit (T1) [for both pre-implementation and post-implementation participants] ]
    Participants' exposure to one or more of the decision aids and timing of exposure, measured using a self-developed item. Note: 'pre-implementation participants' comprise those enrolled in the trial before clinics began implementing interventions and 'post-implementation participants' comprise those enrolled in the trial after clinics began implementing interventions (if relevant).
  • Acceptability of Video [ Time Frame: Immediately after the index health care visit (T1) [for both pre-implementation and post-implementation participants] ]
    The acceptability of the video to participants, measured using a self-developed item. Note: 'pre-implementation participants' comprise those enrolled in the trial before clinics began implementing interventions and 'post-implementation participants' comprise those enrolled in the trial after clinics began implementing interventions (if relevant).
  • Acceptability of Decision Aid(s) [ Time Frame: Immediately after the index health care visit (T1) [for both pre-implementation and post-implementation participants] ]
    The acceptability of the decision aid(s) to participants, measured using a self-developed item. Note: 'pre-implementation participants' comprise those enrolled in the trial before clinics began implementing interventions and 'post-implementation participants' comprise those enrolled in the trial after clinics began implementing interventions (if relevant).
Original Other Pre-specified Outcome Measures
 (submitted: April 29, 2016)
  • Exposure to Video [ Time Frame: Immediately after the index health care visit ]
    Participants' exposure to the video and timing of exposure, measured using an adapted item (Shepherd et al., 2015)
  • Exposure to Prompt Card [ Time Frame: Immediately after the index health care visit ]
    Participants' exposure to the prompt card and timing of exposure, measured using a self-developed item
  • Use of Three Questions [ Time Frame: Immediately after the index health care visit ]
    Participants' use of each of the three patient questions in the health care visit, measured using three adapted items (Shepherd et al., 2015)
  • Exposure to Decision Aid(s) [ Time Frame: Immediately after the index health care visit ]
    Participants' exposure to one or more of the decision aids and timing of exposure, measured using a self-developed item
  • Acceptability of Video [ Time Frame: Immediately after the index health care visit ]
    The acceptability of the video to participants, measured using a self-developed item
  • Acceptability of Decision Aid(s) [ Time Frame: Immediately after the index health care visit ]
    The acceptability of the decision aid(s) to participants, measured using a self-developed item
 
Descriptive Information
Brief Title  ICMJE Right For Me: Birth Control Decisions Made Easier
Official Title  ICMJE Right For Me: Birth Control Decisions Made Easier
Brief Summary Right For Me is a study that aims to improve the conversations patients and health care providers have about birth control. Right For Me will test two different strategies for improving these conversations. The first strategy is to give patients a video to watch that encourages them to ask three specific questions in their health care visit, as well as a prompt card that reminds them of the three questions. The second strategy is to give health care providers a set of decision aids that describe available birth control methods, as well as training in how to use them with patients during the health care visit. Right For Me will test whether introducing one or both of these strategies leads to better conversations than providing health care as usual.
Detailed Description Not Provided
Study Type  ICMJE Interventional
Study Phase  ICMJE Not Applicable
Study Design  ICMJE Allocation: Randomized
Intervention Model: Factorial Assignment
Masking: None (Open Label)
Primary Purpose: Health Services Research
Condition  ICMJE Contraception
Intervention  ICMJE
  • Other: Video + Prompt Card
    1. A brief video (available in English and Spanish) intended to be viewed by patients immediately before the health care visit. The video aims to enhance patients' motivation, skills, and self-efficacy to ask their health care providers three specific questions: (1) What are my options? (2) What are the pros and cons of those options? and (3) How likely are those pros and cons to happen to me?
    2. A prompt card (available in English and Spanish) intended to be provided to patients when they view the video and kept. The card aims to remind patients of the three questions presented in the video.
  • Other: Decision Aids + Training
    1. Seven one-page decision aids on contraceptive methods (available in English and Spanish) intended to be used by health care providers with patients during the health care visit.
    2. A five-minute training video and accompanying written guidance (available in English) intended to be reviewed by health care providers before implementing the decision aids (and as frequently as desired thereafter). The training aims to enhance providers' motivation, skills, and self-efficacy to use the decision aids to facilitate shared decision-making in the health care visit.
Study Arms  ICMJE
  • Experimental: Arm 1
    Intervention: Other: Video + Prompt Card
  • Experimental: Arm 2
    Intervention: Other: Decision Aids + Training
  • Experimental: Arm 3
    Interventions:
    • Other: Video + Prompt Card
    • Other: Decision Aids + Training
  • No Intervention: Arm 4
Publications *

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruitment Information
Recruitment Status  ICMJE Completed
Actual Enrollment  ICMJE
 (submitted: November 17, 2019)
5038
Original Estimated Enrollment  ICMJE
 (submitted: April 29, 2016)
4160
Actual Study Completion Date  ICMJE July 14, 2017
Actual Primary Completion Date December 30, 2016   (Final data collection date for primary outcome measure)
Eligibility Criteria  ICMJE

Inclusion Criteria:

  1. Completed a health care visit at a participating clinic
  2. Assigned female sex at birth
  3. Aged 15 to 49 years
  4. Able to read and write English or Spanish
  5. Not previously participated in the study

Exclusion Criteria:

  1. Not completed a health care visit at a participating clinic (including a patient's parent or a person acting as a patient's legal proxy)
  2. Not assigned female sex at birth
  3. Aged under 15 or over 49 years
  4. Unable to read and write English or Spanish
  5. Previously participated in the study
Sex/Gender  ICMJE
Sexes Eligible for Study: All
Ages  ICMJE 15 Years to 49 Years   (Child, Adult)
Accepts Healthy Volunteers  ICMJE No
Contacts  ICMJE Contact information is only displayed when the study is recruiting subjects
Listed Location Countries  ICMJE United States
Removed Location Countries  
 
Administrative Information
NCT Number  ICMJE NCT02759939
Other Study ID Numbers  ICMJE 00028721
Has Data Monitoring Committee No
U.S. FDA-regulated Product Not Provided
IPD Sharing Statement  ICMJE
Plan to Share IPD: Yes
Plan Description: The investigators will make an anonymized copy of the final participant-level data set and essential analysis syntax available to others for research purposes, either via data sharing on request or via digital repository deposition, before October 2018.
Responsible Party Rachel L. Thompson, Dartmouth-Hitchcock Medical Center
Study Sponsor  ICMJE Dartmouth-Hitchcock Medical Center
Collaborators  ICMJE Not Provided
Investigators  ICMJE
Principal Investigator: Rachel Thompson, PhD Dartmouth College
PRS Account Dartmouth-Hitchcock Medical Center
Verification Date November 2019

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP